64 completed, 11 terminated, 6 recruiting, 6 unknown. 90 Phase 2, 12 Phase 1, 3 Phase 3.
Follow Testicular Diseases: new trials by email Literature Review of Testicular Diseases trials Research Report on Testicular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) Pedmark® STS - Solid Tumor Malignancies, Testicular Cancer | Phase 1 / Phase 2 | Recruiting | University of Arizona | 25 | 2026-05-18 | 2026-06-18 |
| Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy - Melanoma, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Recruiting | University of Arizona | 30 | 2025-09-08 | 2026-10-06 |
| A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy Low-dose ASA - Germ Cell Tumor, Testicular Cancer | Phase 2 | Recruiting | Wake Forest University Health Sciences | 35 | 2025-08-28 | 2026-07-24 |
| A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases Retroperitoneal Lymph Node Dissection - Testicular Cancer | Phase 2 | Recruiting | Western University, Canada | 30 | 2025-07-17 | 2025-07-20 |
| A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm CLDN6 CAR-T, CLDN6 RNA-LPX - Testicular Germ Cell Tumor, Extragonadal Germ Cell Tumor | Phase 2 | Withdrawn | BioNTech SE | 2025-07-01 | 2025-07-02 | |
| Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3) Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer | Phase 2 | Completed | University of Southern California | 120 | 2025-01-16 | 2026-05-06 |
| Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors Albumin-paclitaxel Injection - Paget Disease, Extramammary, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 100 | 2024-11-30 | 2024-12-20 |
| Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline Paclitaxel, Bleomycin, Etoposide - Germ Cell Cancer Metastatic | Phase 2 | Recruiting | Blokhin's Russian Cancer Research Center | 60 | 2024-10-01 | 2026-10-26 |
| Agnostic Therapy in Rare Solid Tumors Nivolumab - Urachal Cancer, Parathyroid Carcinoma | Phase 2 | Active not recruiting | Instituto do Cancer do Estado de São Paulo | 28 | 2024-07-16 | 2026-10-13 |
| Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma Carboplatin, Cisplatin, Etoposide - Seminoma, Testicular Cancer | Phase 2 | Active not recruiting | Swiss Cancer Institute | 135 | 2019-07-29 | 2026-01-20 |
| Short-term Testosterone Replacement in Testicular Cancer Survivors Androgel (Testosterone gel), Placebo gel - Testicular Cancer | Phase 2 | Completed | University Medical Center Groningen | 32 | 2018-12-21 | 2024-07-30 |
| A Biobehavioral Intervention for Young Men With Testicular Cancer Goal-Focused Emotion Regulation Therapy (GET), Individual Supportive Psychotherapy (ISP) - Testis Cancer | Phase 2 | Unknown | University of California, Irvine | 100 | 2018-11-01 | 2020-12-19 |
| Avelumab in Refractory Testicular Germ Cell Cancer. Avelumab - Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal | Phase 2 | Completed | National Cancer Institute, Slovakia | 8 | 2017-11-15 | 2019-03-05 |
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors Durvalumab, Tremelimumab - Germ Cell Tumor | Phase 2 | Terminated | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 36 | 2017-02-01 | 2021-05-14 |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers Durvalumab, Tremelimumab, Poly-ICLC - Head and Neck Squamous Cell Carcinoma, Breast Cancer | Phase 1 / Phase 2 | Completed | Ludwig Institute for Cancer Research | 58 | 2016-12-28 | 2022-12-02 |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors Testosterone, Placebos - Metabolic Syndrome, Testicular Cancer | Phase 2 / Phase 3 | Completed | Mikkel Bandak | 69 | 2016-11-01 | 2020-03-06 |
| Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer Veliparib, Gemcitabine, Carboplatin - Testicular Cancer | Phase 2 | Completed | National Cancer Institute, Slovakia | 15 | 2016-08-01 | 2021-03-03 |
| Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer | Phase 2 | Terminated | Nabil Adra | 18 | 2016-03-09 | 2019-12-10 |
| Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Pembrolizumab - Germ Cell Neoplasms, Testicular Neoplasms | Phase 2 | Terminated | Nasser Hanna, M.D. | 12 | 2016-01-01 | 2022-07-11 |
| Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer cabazitaxel - Testicular Cancer | Phase 2 | Terminated | University Hospital, Akershus | 14 | 2015-06-01 | 2024-02-02 |
Showing 20 of 90. Sign in to see all of them.
Testicular Neoplasms (83) · Testicular Germ Cell Tumor (35) · Ovarian Neoplasms (31) · Teratoma (22) · Neuroblastoma (18) · Carcinoma, Embryonal (17) · Endodermal Sinus Tumor (17) · Seminoma (17) · Breast Neoplasms (16) · Burkitt Lymphoma (16) · Carcinoma, Ovarian Epithelial (15) · Lymphoma, Large B-Cell, Diffuse (15) · Neoplasms, Germ Cell and Embryonal (15) · Hodgkin Disease (14) · Leukemia, Lymphocytic, Chronic, B-Cell (14)
Endocrine System Diseases (90) · Genital Diseases (90) · Genital Diseases, Male (90) · Male Urogenital Diseases (90) · Urogenital Diseases (90) · Gonadal Disorders (89) · Endocrine Gland Neoplasms (87) · Neoplasms by Site (87) · Urogenital Neoplasms (87) · Genital Neoplasms, Male (86) · Neoplasms (79) · Neoplasms by Histologic Type (66) · Female Urogenital Diseases (49) · Female Urogenital Diseases and Pregnancy Complications (49)
Carboplatin (20) · Etoposide (18) · Paclitaxel (18) · Filgrastim (17) · Ifosfamide (16) · Cisplatin (15) · Peripheral Blood Stem Cell Transplantation (9) · Bleomycin (7) · Gemcitabine (6) · Thiotepa (5) · etoposide phosphate (5) · pegfilgrastim (5) · Cyclophosphamide (4) · Epirubicin (3) · Granulocyte Colony-Stimulating Factor (3)
Memorial Sloan Kettering Cancer Center (11) · Fred Hutchinson Cancer Center (7) · National Cancer Institute (NCI) (5) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (4) · City of Hope Medical Center (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · Children's Oncology Group (2) · Masonic Cancer Center, University of Minnesota (2) · Medical Research Council (2) · National Cancer Institute, Slovakia (2) · University of Arizona (2) · University of Southern California (2) · Wake Forest University Health Sciences (2) · AHS Cancer Control Alberta (1) · Abramson Cancer Center at Penn Medicine (1)
United States (55) · Italy (10) · United Kingdom (7) · Canada (5) · Denmark (5) · France (5) · Germany (5) · Netherlands (4) · Slovakia (4) · Switzerland (4) · Belgium (3) · Norway (3) · Australia (2) · Austria (2) · China (2)
Robert J. Motzer, MD (4) · Andrea Necchi, MD (2) · Brian H. Kushner, MD (2) · Darren Feldman, MD (2) · Gnanamba V. Kondagunta, MD (2) · Jubilee Brown (2) · Alejandro Recio-Boiles, MD (1) · Alessandro M Gianni, MD (1) · Alessandro M. Gianni, MD (1) · Alexander McEwan, MD (1) · Alexandros Papachristofilou, MD (1) · Anastasios Raptis, MD (1) · Andrea Isidori, MD, PhD (1) · Andrea Lenzi, MD (1) · Barry L. Gause, MD (1)
PMID 11919245, PMID 15999102, PMID 15999362, PMID 16688776, PMID 17194908, PMID 17290059, PMID 19547919, PMID 19841031, PMID 20194867, PMID 21875697, PMID 24894084, PMID 25001888, PMID 25344361, PMID 26199392, PMID 26838019, PMID 28673265, PMID 29045540, PMID 30232558, PMID 30243800, PMID 30302881, PMID 31532522, PMID 32290859, PMID 32641862, PMID 32692450, PMID 34052929, PMID 34223605, PMID 35514022, PMID 35701334, PMID 37078969, PMID 39265466
P30CA008748 (5), U10CA027469 (3), U10CA180868 (3), P30CA033572 (2), U10CA098543 (2), 2009 (1), 2019 (1), N01CM00071 (1), N01CM62206 (1), P30CA006516 (1), P30CA043703 (1), U01CA062491 (1), U01CA062505 (1), U01CA069856 (1), U01CA069912 (1)